Journal of Mind and Medical Sciences
Volume 6 | Issue 2

Article 11

2019

Indocyanine green utility in sentinel node
detection for cervical cancer patients
Nicolae Bacalbașa
Irina Balescu
Cristian Balalau
Mihaela Vilcu
Iulian Brezean

Follow this and additional works at: https://scholar.valpo.edu/jmms
Part of the Oncology Commons, Preventive Medicine Commons, Primary Care Commons, and
the Surgery Commons

Recommended Citation
Bacalbașa, Nicolae; Balescu, Irina; Balalau, Cristian; Vilcu, Mihaela; and Brezean, Iulian (2019) "Indocyanine green utility in sentinel
node detection for cervical cancer patients," Journal of Mind and Medical Sciences: Vol. 6 : Iss. 2 , Article 11.
DOI: 10.22543/7674.62.P248252
Available at: https://scholar.valpo.edu/jmms/vol6/iss2/11

This Review Article is brought to you for free and open access by ValpoScholar. It has been accepted for inclusion in Journal of Mind and Medical
Sciences by an authorized administrator of ValpoScholar. For more information, please contact a ValpoScholar staff member at scholar@valpo.edu.

https://scholar.valpo.edu/jmms/
https://proscholar.org/jmms/
ISSN: 2392-7674

J Mind Med Sci. 2019; 6(2): 248-252
doi: 10.22543/7674.62.P248252

Received for publication: April 22, 2019
Accepted: June 14, 2019

Review
Indocyanine green utility in sentinel node
detection for cervical cancer patients
Nicolae Bacalbașa1,2,3, Irina Balescu4*, Cristian Balalau2,5, Mihaela Vilcu1,2,
Iulian Brezean1,2
1

Ion Cantacuzino Clinical Hospital, Bucharest, Romania
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
3
Center of Excellence in Translational Institute, Fundeni Clinical Institute, Bucharest, Romania
4
Ponderas Academic Hospital, Bucharest, Romania
5
Pantelimon’ Clinical Hospital, Bucharest, Romania
2

Abstract

With wide implementation of screening tests for the Human Papilloma Virus, the
number of diagnosed cases of premalignant or early stages of cervical cancer has increased
considerably. As a consequence, surgeons’ attention has focused on determining how best
to limit the surgical procedure so the benefits of the procedure will not be surpassed by
postoperative morbidity. In this respect, extended lymph node dissection, routinely
associated so far with cervical cancer patients, has in the last decades been replaced with
sentinel node detection and biopsy. Initially performed through radiocolloid injection, this
method has undergone permanent changes in order to maximize its efficacy and safety.
Although the laparoscopic approach had been widely used in the past, a new method has
been proposed, i.e., the use of indocyanine green injection, which has yielded promising
results for sentinel node detection in the early stages of cervical carcinoma. This paper
reviews the literature of the most relevant studies conducted on this topic.
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Highlights

✓ Sentinel lymph node detection by using indocyanine green injection seems to be a safe
and effective method in cervical cancer patients.

cervical cancer, sentinel lymph node detection, indocyanine green

✓ Attention should be paid to the method of dilution and injection of this product, in order
to avoid the association of false positive results.
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Introduction
The benefits of detecting the sentinel node were
demonstrated in cases of solid tumors almost a century ago.
More recently, the method again proved safe and effective
in treating other gynecologic malignancies such as breast
cancer and vulvar cancer (1-4).
Regarding cervical cancer, the technique of sentinel
node biopsy has been implemented since 1996 and
consisted of blue dye and/or radiocolloid injection.
Although the method had encouraging results, it
nevertheless failed in detecting bilateral sentinel lymph
nodes in almost half the patients. As a consequence, a
significant number of patients were further subjected to
extended lymph node dissection even though the malignant
process had been diagnosed in an early stage of the disease
(5, 6). However, the failure to detect the sentinel nodes
argued in favor of searching for a more specific tracer.
Specifically, the administration of radioisotopes such as
Technetium proved to be painful to the patient, expensive,
challenging for the team, and even dangerous due to
possible radioactive contamination after the injection (7,
8). Other tracers such as blue dye, although less costly,
were associated with rapid clearance from the sentinel
nodes, meaning they could no longer be detected after a
period of time. Specifically, due to the reduced dimensions
of the molecules, these dyes seemed to be associated with
a rapid migration from the level of the sentinel nodes.
Therefore, by the time of surgery, the true sentinel nodes
might be missed, while the blue dye accumulates at the
level of the next lymph node stations. As a result, the rates
of false positives increase and the effectiveness of the
method decreases (9, 10). Moreover, the injection of such
dyes is sometimes associated with allergic reactions,
including anaphylactic shock (9-11). For these reasons,
there was need to identify other types of tracers that could
provide a higher rate of detection, with lower rates of
adverse reactions and better identification of the sentinel
nodes bilaterally (12).

Discussions
The utility of indocyanine green for sentinel lymph node
detection in gynecologic malignancies.
This method uses an indocyanine green injection
(approved by the FDA for many years) and the near
infrared fluorescence imaging, due to the fluorescent
properties of this substance in the 700-900 nm light
spectrum (13). According to a study by Jewell and
colleagues, the method consists in diluting a 25 mg vial in
20 cc of sterile water, thus obtaining a concentration of

1.25 mg/ml, and injecting one cc at 3 pm and 9 pm in the
superficial and deep layer respectively at the level of the
uterine cervix. The injection was done just after draping the
patient, but before the insertion of the uterine manipulator
and prior to laparoscopic surgery (12). Another site of
injection is the endocervical or intrauterine cavity during
hysteroscopy. The intracervical injection has been
associated with the best results due to the presence of rich
parametrial lymphatic drainage.
However, when the surgeon decides to inject the
indocyanine green, several points should be considered: the
product contains up to 5% iodine-based excipients, so it
cannot be used in patients with known allergies to iodine;
the substance should be diluted in sterile water and not in
other substances such as sodium chloride (due to the fact
that it is not readily soluble in saline solution), and the fact
that the product is a negatively charged ion should be
noted. Moreover, if the product is dissolved in saline
solutions, the molecules trend to aggregate, influencing the
optical properties (14, 15). In addition, once the product is
dissolved, it should be kept in a dark room in order to
preserve its fluorescent properties (16).
An interesting study on the topic of the influence of the
concentration and volume of the injected indocyanine
green was conducted by Xiong et al. (2014). In this study,
cases in which the concentration was lower than 5 mg/ml
and the volume was higher than 2 ml were associated with
the best rates of detection of sentinel nodes in cervical
cancer patients (17). Furthermore, according to the
National Comprehensive Cancer Network (NCCN)
Guidelines, Version 1.2018, the indocyanine green
injection should be administered at the level of the uterine
cervix, while the sentinel nodes are usually located medial
to the external iliac vessels, ventral to the internal iliac
vessels or at the level of the superior area of the obturator
fossa (18).
However, debates regarding the protocol of
indocyanine green injection in cervical cancer patients
stem from the relatively low number of cases making use
of this therapeutic protocol. Once the number of cases
increases, a more standardized protocol can be expected.
Moreover, similar to other malignancies, synchronous
intracervical and intrauterine injection might also be
considered. For colorectal cancer, some authors have
proposed synchronous submucosal and subserosal
injection with encouraging results (19). According to a
meta-analysis by Emile, the submucosal and subserosal
injection of indocyanine green in association with
preoperative injection is correlated with a significantly
higher rate of sentinel node detection (19).
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Indocyanine green sentinel node detection as part of a
dual method
To test the efficacy of the method, indocyanine green
injection was initially used as part of a dual method of
detection, in association with blue dye injection or with
radiotracer administration. Jewel et al. (2014) analyzed the
results of 227 patients with uterine malignancies submitted
to surgery between 2011 and 2013 at the Memorial Sloan
Kettering Cancer Center, in New York, the USA (12).
Among these cases, the final histopathological studies
confirmed the cervical origin of the malignancy in 18
cases. Among the entire cohort, the median time for
detecting the sentinel node following injection was 30
minutes, while the median number of identified sentinel
nodes was 3. Indocyanine green was used as a single
method to detect the sentinel node in 87% of cases, while
the remaining 13% of cases benefited from the dual method
consisting of combined indocyanine green and blue dye
injection. The authors reported no significant difference in
terms of sentinel node detection after the indocyanine
green injection alone or in association with blue dye
injection. However, the rates of bilateral lymph node
detection were an improvement over other techniques, thus
demonstrating the efficacy of the method. Therefore, the
overall detection rate was 95%, while the rate of bilateral
detection was 79%. However, the authors underscore the
fact that even if indocyanine green injection is used, the
rates of detection are still poor among patients with a
higher body mass index. The authors further observed that
no additional lymph nodes were eventually found after blue
dye injection when compared to indocyanine green
injection, so they excluded the use of blue dye and injected
only indocyanine green. As for the use of technetium, the
higher rates of bilateral lymph node detection reported after
indocyanine green injection as well as the various
limitations of technetium injection (higher costs, exposure
to radioactivity) led the authors to support the superiority
of the fluorescent method (12).
One of the more relevant studies demonstrating the
safety and efficacy of indocyanine green injection in
uterine cancer malignancies was conducted by Anabela
Rocha and colleagues, published in 2016 (16). The article
reviewed papers published on this topic between January
2010 and May 2015, reviewing data from 10 studies
involving 422 patients: 368 cases submitted to robotic
surgery, 15 cases to laparoscopic surgery, and 10 cases to
open surgery. Of these reports, six studies focused on
cervical cancer patients. The authors emphasized the fact
that the indocyanine green injection occurred at the level
of the uterine cervix or directly into the uterine cavity
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through hysteroscopy. However, the intracervical injection
was associated with a significantly higher rate of sentinel
node detection. Among the reviewed studies, the mean
number of retrieved lymph nodes was 4.7, no complication
being related to the indocyanine green administration.
Similar to the previous study, this paper also highlighted
the importance of the indocyanine green injection in
providing bilateral sentinel lymph node detection, the
detection rates for bilateral mapping being of 97% for
indocyanine green injection and 77% for blue dye
injection. Moreover, studies which used indocyanine green
alone or in association with isosulfan blue injection
demonstrated that the detection rate was even higher when
indocyanine green was administered alone. As for the
method of injection, multiple techniques have been
proposed. While most studies involved injecting
indocyanine green at the level of the uterine cervix just
before inducing the pneumoeperitoneum (in minimally
invasive surgery) or just before performing the incision (in
open surgery), other studies injected the dye directly in the
uterine wall by hysteroscopy before beginning the surgical
procedure. Moreover, other authors have injected the dye
into the uterine cervix immediately after exposing the
pelvic lymph nodes. As for the period of time between the
injection and the intra-abdominal detection of the
indocyanine green, various intervals (between 29 and 69
minutes) have been reported. However, 30 minutes might
be considered an approximate time of migration (16).
In order to increase the rates of sentinel node detection
after indocyanine green injection, some authors have
proposed the combination of indocyanine green and human
serum albumin. Currently, however, this combination has
not demonstrated superiority, similar rates of sentinel node
detection being reported for both two methods (20).

Conclusions
Sentinel lymph node detection by using indocyanine
green injection seems to be a safe and effective method in
cervical cancer patients. The method has been associated
with increased rates of sentinel node detection and bilateral
mapping while the rates of adverse reaction are almost null.
Moreover, the method appears to improve results when
used as a single agent or as part of a dual method. However,
attention should be paid to the method of dilution and
injection of this product in order to avoid the association of
false positive results.
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